Clinical Trial Update: Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating teriparatide (FORTEO) for adults with osteogenesis imperfecta; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Osteogenesis Imperfecta | Phase 4 | Status: COMPLETED | Results posted: 2019-04-24